@theneurondaily: Who Can Afford Personalized Gene Editing? 🧬 For some genetic diseases, treatments tailored to a person's biology may already be technically possible. But the cost of developing and delivering them puts them beyond most patients' reach. Dr. Trevor Martin, co-founder and CEO of Mammoth Biosciences, explains why scaling genetic medicine is such a major challenge. Conditions like sickle cell disease affect populations with limited access to expensive therapies, raising questions about how to make these treatments affordable without overwhelming healthcare systems. 👉 Watch the full episode of "Can AI Help Cure Genetic Disease?" on The Neuron: AI Explained Podcast — available on all major podcast platforms and YouTube. #GeneEditing #PersonalizedMedicine #CRISPR #GeneticMedicine #MammothBiosciences #TheNeuron

The Neuron - AI Newsletter

Open In TikTok:

Region: US

Monday 26 October 2026 22:00:09 GMT